rss icon

Life Sciences (13)

GRAND RAPIDS — Grand River Aseptic Manufacturing Inc. was struggling in late 2010 when a group of West Michigan investors put up $5 million to acquire the company’s assets.

Michigan ranked third among 11 Midwest regions for the value of equity investments made in life sciences companies during the first half of 2017.

At some point in the coming months, Mark Gurney and directors at Tetra Discovery Partners LLC will decide which road to travel into the future for their company.


The availability of scientific and executive management talent and the access to later-stage investment capital remain major issues for Michigan’s life sciences industry.

GRAND RAPIDS — Over the course of four years, Michigan State University researchers managed to take about $300,000 and turn it into more than $4.5 million.

KALAMAZOO — Six months after raising its first round of capital, Innovative Cardiovascular Solutions LLC seeks to raise another $5 million that will position the company for a clinical trial and regulatory application in Europe, as well as an eventual sale.

GRAND RAPIDS — Michigan State University will seek to raise about $30 million to help pay for the $88.1 million biomedical research center that will add to the growing research cluster in Grand Rapids.

Once touted as a bright example of the growing life sciences sector in West Michigan and a new era of molecular medicine, Sequenom Inc. now plans to shut down its local lab.

Metabolic Solutions Development Co. plans to seek $25 million to $35 million in additional capital later this year to support the continued development of its new drug targets.

After naming a new CEO and CFO last month and closing on the first round of a $2.5 million capital raise, Armune BioScience Inc. aims to move into the marketplace this spring with a new-generation blood test for men suspected of having prostate cancer.

With $5 million in new investor capital, a Kalamazoo-based startup can now move to design and initiate human testing of a medical device intended to protect against strokes during heart procedures.

MATTAWAN — Leaders of MPI Research, INVICRO and 3D Imaging have entered into a collaboration designed to accelerate the drug discovery and development process.

Q&A: Jana Hall, Van Andel Institute

Written by | Sunday, 07 July 2013 22:00 |

A 20-year veteran of research administration and operations and management, and a geneticist by training, Jana Hall leads Van Andel Institute’s day-to-day operations as chief operations officer, a position she started last fall. She oversees I.T., human resources, materials management, logistics, security, finance, and business development. 

Breaking News

October 2018
30 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31 1 2 3

Follow MiBiz